The Latest
-
Immuron share price shoots 6% higher after receiving FDA guidance for new drug
-
Is the Zip share price a buy after falling 20% last week?
-
Britain signs deals with Pfizer, BioNTech, Valneva for COVID-19 vaccines
-
Buy and hold these mid cap ASX shares for strong potential returns